186 related articles for article (PubMed ID: 10330445)
1. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.
Wang RF; Wang X; Rosenberg SA
J Exp Med; 1999 May; 189(10):1659-68. PubMed ID: 10330445
[TBL] [Abstract][Full Text] [Related]
2. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.
Pieper R; Christian RE; Gonzales MI; Nishimura MI; Gupta G; Settlage RE; Shabanowitz J; Rosenberg SA; Hunt DF; Topalian SL
J Exp Med; 1999 Mar; 189(5):757-66. PubMed ID: 10049939
[TBL] [Abstract][Full Text] [Related]
3. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
[TBL] [Abstract][Full Text] [Related]
4. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.
Wang RF; Wang X; Atwood AC; Topalian SL; Rosenberg SA
Science; 1999 May; 284(5418):1351-4. PubMed ID: 10334988
[TBL] [Abstract][Full Text] [Related]
5. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.
Nishimura MI; Avichezer D; Custer MC; Lee CS; Chen C; Parkhurst MR; Diamond RA; Robbins PF; Schwartzentruber DJ; Rosenberg SA
Cancer Res; 1999 Dec; 59(24):6230-8. PubMed ID: 10626817
[TBL] [Abstract][Full Text] [Related]
6. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
[TBL] [Abstract][Full Text] [Related]
7. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design.
Zeng G
J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496
[TBL] [Abstract][Full Text] [Related]
8. Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.
Wang HY; Zhou J; Zhu K; Riker AI; Marincola FM; Wang RF
J Exp Med; 2002 Jun; 195(11):1397-406. PubMed ID: 12045238
[TBL] [Abstract][Full Text] [Related]
9. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
Jäger E; Jäger D; Karbach J; Chen YT; Ritter G; Nagata Y; Gnjatic S; Stockert E; Arand M; Old LJ; Knuth A
J Exp Med; 2000 Feb; 191(4):625-30. PubMed ID: 10684854
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
11. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.
Robbins PF; el-Gamil M; Li YF; Topalian SL; Rivoltini L; Sakaguchi K; Appella E; Kawakami Y; Rosenberg SA
J Immunol; 1995 Jun; 154(11):5944-50. PubMed ID: 7751637
[TBL] [Abstract][Full Text] [Related]
12. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
13. Minor structural changes in a mutated human melanoma antigen correspond to dramatically enhanced stimulation of a CD4+ tumor-infiltrating lymphocyte line.
Sundberg EJ; Sawicki MW; Southwood S; Andersen PS; Sette A; Mariuzza RA
J Mol Biol; 2002 May; 319(2):449-61. PubMed ID: 12051920
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity.
Donia M; Andersen R; Kjeldsen JW; Fagone P; Munir S; Nicoletti F; Andersen MH; Thor Straten P; Svane IM
Cancer Res; 2015 Sep; 75(18):3747-59. PubMed ID: 26183926
[TBL] [Abstract][Full Text] [Related]
15. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.
Wang RF; Robbins PF; Kawakami Y; Kang XQ; Rosenberg SA
J Exp Med; 1995 Feb; 181(2):799-804. PubMed ID: 7836932
[TBL] [Abstract][Full Text] [Related]
16. Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.
Maccalli C; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
Cancer Res; 2003 Oct; 63(20):6735-43. PubMed ID: 14583468
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
18. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.
Li Y; Depontieu FR; Sidney J; Salay TM; Engelhard VH; Hunt DF; Sette A; Topalian SL; Mariuzza RA
J Mol Biol; 2010 Jun; 399(4):596-603. PubMed ID: 20417641
[TBL] [Abstract][Full Text] [Related]
20. Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells.
Wang RF
Methods; 2003 Mar; 29(3):227-35. PubMed ID: 12725788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
